Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Tabernaemontana
Intensivist/patient ratios in closed ICUs: a statement from the Society of Critical Care Medicine Taskforce on ICU Staffing.
Poor visual discrimination and visual hallucinations in Parkinson's disease.
Race and Apolipoprotein E-e4 Allele Status Differences in the Association Between Loneliness and Cognitive Decline.
What influences placebo and nocebo responses in Parkinson's disease?
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
What influences placebo and nocebo responses in Parkinson's disease?
What influences placebo and nocebo responses in Parkinson's disease? Mov Disord. 2018 08; 33(8):1204-1212.
View in:
PubMed
subject areas
Catechol O-Methyltransferase
History, 18th Century
History, 19th Century
Humans
Nocebo Effect
Parkinson Disease
Placebo Effect
Polymorphism, Single Nucleotide
Treatment Outcome